0000899243-22-001743.txt : 20220112
0000899243-22-001743.hdr.sgml : 20220112
20220112160512
ACCESSION NUMBER: 0000899243-22-001743
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220101
FILED AS OF DATE: 20220112
DATE AS OF CHANGE: 20220112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TZIANABOS ARTHUR
CENTRAL INDEX KEY: 0001586226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 22526653
MAIL ADDRESS:
STREET 1: C/O HOMOLOGY MEDICINES, INC.
STREET 2: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Homology Medicines, Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-301-7277
MAIL ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-01
0
0001661998
Homology Medicines, Inc.
FIXX
0001586226
TZIANABOS ARTHUR
C/O HOMOLOGY MEDICINES INC.,
ONE PATRIOTS PARK
BEDFORD
MA
01730
1
1
0
0
President & CEO
Common Stock
2022-01-01
4
M
0
13860
A
91365
D
Common Stock
2022-01-05
4
S
0
5354
3.7802
D
86011
D
Restricted Stock Units
2022-01-01
4
M
0
13860
0.00
D
Common Stock
13860
28140
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.
The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.80. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.
The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.
/s/ W. Bradford Smith, Attorney-in-Fact for Arthur Tzianabos
2022-01-12